GSK Investigational Site

East Lansing, Michigan 48824

0 studies enrolling now · 4 studies all time

What they study most

Bipolar Disorder, HIV Infections, Infection, Human Immunodeficiency Virus, Sepsis

Studies at this site

• Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.) — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) — Completed